1.Analysis of the efficacy of traditional Chinese medicine for diabetic retinopathy based on evidence body quality assessment
Juan LING ; Zhuolin XIE ; Xiangxia LUO ; Wanying GUO ; Jiajin LI ; Jun ZHOU ; Xufei LUO
China Pharmacy 2025;36(7):863-866
OBJECTIVE To evaluate the quality of evidence in the systematic evaluation/meta-analysis of traditional Chinese medicine (TCM) for diabetes retinopathy (DR) based on the GRADE system. METHODS Chinese and English databases were searched to obtain the relevant studies of systematic evaluation/meta-analysis of traditional Chinese medicine in the treatment of DR. The search time was from the establishment of each database to January 13th, 2024. According to the inclusion and exclusion criteria, literature screening was conducted. After extracting relevant information from the included literature, the GRADE system was used to evaluate the quality level of the evidence body in the included studies, and the evidence of the outcome indicators was integrated and summarized. RESULTS A total of 51 studies were ultimately included, encompassing 135 outcome indexes. Among these, 19 indicators (14.1%) were of high quality, 87 (64.4%) were of medium quality, 26 (19.3%) were of low quality, and 3 (2.2%) were of very low quality. Overall, the evidence quality of the outcome indicators in the included studies was medium to low quality. The integrated results of evidence on the efficacy of outcome indexes showed that compared with conventional Western medicine, calcium dobesilate or placebo, TCM had significant advantages in improving overall efficacy, reducing bleeding spot area, reducing macular foveal thickness, and increasing visual improvement rate. In addition,the combination of TCM and conventional Western medicine or calcium dobesilate was significantly more effective than using conventional Western medicine or calcium dobesilate alone. CONCLUSIONS The overall quality of the evidence in the systematic evaluation/meta-analysis study on the treatment of DR with TCM is medium to low quality. Based on existing research findings, TCM demonstrates good clinical efficacy in the treatment of DR.
2.The value of breast MRI-abbreviated protocol with full field digital mammography and breast MRI-full diagnostic protocol in the diagnosis of early breast cancer with non-calcified manifestations
Dongxue ZHANG ; Shuilan ZHANG ; Yingying DING ; Zhuolin LI
Journal of Practical Radiology 2024;40(4):567-571
Objective To investigate the value of breast MRI-abbreviated protocol(BMRI-AP)compared with full field digital mammography(FFDM)and breast MRI-full diagnostic protocol(BMRI-FDP)in the diagnosis of early breast cancer with non-calcified.Methods A total of 95 cases patients with early breast cancer with non-calcified(the longest diameter of the lesion≤2 cm,regardless of the size of the carcinoma in situ)were retrospectively included.Clinical,pathological and imaging data of all patients were collected.All patients underwent FFDM and MRI scanning,and three examination regimens,including FFDM,BMRI-AP,BMRI-FDP,were further obtained.Classification was performed according to the breast imaging reporting and data system(BI-RADS)classification standard(fifth edition)developed by American College of Radiology(ACR),and pathological results were taken as the standard.The diagnostic efficacy for early breast cancer with non-calcified were compared among the different three imaging methods.Results The diagnostic accuracy of FFDM,BMRI-AP and BMRI-FDP for early breast cancer with non-calcified was 76.84%,93.68%and 95.79%,respectively,with statistically significant difference among three groups(χ2=20.558,P<0.001).The median(quartile distance)of BMRI-AP and BMRI-FDP scanning time were 478(5)s and 926(13)s,respectively,with statistically significant difference between the two groups(Z=-11.912,P<0.001).Conclusion The diagnostic accuracy of BMRI-AP is significantly better than that of FFDM and similar to that of BMRI-FDP for early breast cancer with non-calcified.In addition,BMRI-AP can significantly shorten the scanning time without reducing the diagnostic accuracy,which is expected to become a new breast cancer screening method.
3.Economic Evaluation of Tiotropium/Olodaterol and Tiotropium in the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Yajie GU ; Zhuolin ZHANG ; Zhuangyin QU ; Linzhe DU ; Sheng LOU ; Xin LI ; Junrong ZHU
Herald of Medicine 2024;43(9):1480-1486
Objective To evaluate the cost-utility of tiotropium/olodaterol in treating Chinese patients with moderate to very severe chronic obstructive pulmonary disease(COPD)and to provide references for selecting more economical inhaled preparations in clinical practice.Methods A four-state lifetime Markov model was established with a 3-month cycle.The health outcomes included life years and quality-adjusted life years.Costs,including direct medical costs,were calculated from the perspective of the Chinese health system.Discontinuation rates were derived from the discontinuation curve using GetData Graph Digitizer.The main output indicator of the model was the incremental cost-utility ratio,which was calculated from the queue simulation results to judge the economy of tiotropium bromide/odataterol.The scenario analysis and sensitivity analyses were carried out to detect the robustness of the base case result.Results Compared with tiotropium bromide,the patient treated with tiotropium bromide/odataterol gained an additional 0.0846 life years,an additional cost of ¥3 201.50,and additional 0.029 6 QALY.The incremental cost-utility ratio was 108 140.11 yuan/QALY,lower than the willingness-to-pay threshold of three times China's per capita GDP in 2021.The costs of tiotropium bromide and tiotropium bromide/odataterol had the greatest impact on the result in the one-way sensitivity analysis.93.8%of the Chinese COPD population was willing to pay for tiotropium bromide/odataterol under the threshold in the probability sensitivity analysis.Conclusion Tiotropium/olodaterol is a cost-effective alternative compared to tiotropium for patients with moderate to very severe COPD in China and the results were robust in the sensitivity analyses.
4.Exploring mechanism and experimental validation of Gubiao Fanggan Modified Formula in preventing influenza virus in immunosuppressive mice based on network pharmacology
Xinyue MA ; Jiawang HUANG ; Mengchen ZHU ; Zhuolin LIU ; Ziye XU ; Fangguo LU ; Ling LI
Chinese Journal of Immunology 2024;40(7):1447-1453,中插2-中插5
Objective:To invastigate the targets and signaling pathways of Gubiao Fanggan Modified Formula in regulating the defense against influenza A virus in immunosuppressed mice by network pharmacology,and the key targets were verified by immuno-suppressive mice model.Methods:TCMSP database was used to search the active ingredients of Gubiao Fanggan Modified Formula,and GeneCard,OMIM,PharmGkb databases were used to obtain the potential targets of the active ingredients to prevent influenza,and take their intersection targets were taken;STRING11.5 database was used to make protein-protein interaction network analyzed and finded the core targets;Cytoscape3.8.1 was used to build a traditional Chinese medicine-ingredient-disease target network,and GO enrichment analysis and KEGG enrichment analysis were performed.Intraperitoneal injection of cyclophosphamide was used to construct a mouse model of immune function suppression,normal group,model control group,Gubiao Fanggan Modified Formula group and oseltamivir group were set up,followed by prophylactic administration,and influenza virus intervention was performed on the fourth day.After 7 days of intragastric administration,the key targets were verified by mouse spleen index,HE staining,RT-qPCR and immunohistochemistry.Results:There were 82 active ingredients in five traditional Chinese medicines in Gubiao Fanggan Modi-fied Formula,and 72 common targets of drugs and diseases such as IL-6,TNF-α,IL-2,etc,mainly involving IL-17,TNF and AGE-RAGE signaling pathway.Gubiao Fanggan Modified Formula could increase spleen index and significantly reduce mRNA and protein expressions of IL-6 and TNF-α in spleen tissue of mice(P<0.05 or P<0.01).Conclusion:Gubiao Fanggan Modified Formula may regulate body's immune function through targets such as IL-6 and TNF-α,thereby preventing influenza virus infection.
5.Effect of Interval Between Neoadjuvant Chemotherapy and Surgery on Oncological Outcomes in Poor Responders With Locally Advanced Breast Cancer
Man LONG ; Chunxia LI ; Keyu MAO ; Zhenhui LI ; Zhen LI ; Guili DONG ; Xia ZHENG ; Songliang GAO ; Zhuolin LI ; Guangjun YANG ; Yu XIE
Journal of Breast Cancer 2024;27(4):270-280
Purpose:
The interval between neoadjuvant chemotherapy (NAC) and surgery for locally advanced breast cancer (LABC) remains controversial. At the same time, the prognostic effect of delayed surgery in patients with poor responses is currently unclear.
Methods:
Data was collected from patients who had poor responses to NAC and underwent modified radical surgery from January 2013 to December 2018. The interval from completion of NAC to surgery was divided into two groups: a longer (greater than four weeks) or shorter (four weeks or less) interval. The associations of these interval groups with overall survival (OS) and recurrence-free survival (RFS) were evaluated by multivariable Cox models adjusting for the existing prognostic factors. Propensity score matching (PSM) was used to minimize election bias.
Results:
A total of 1,229 patients (mean age, 47.2 ± 8.9 years; median follow-up duration, 32.67 [6.57–52.63] months) were included. The 5-year OS rates were 73.2% and 60.8% in the shorter (n = 171) and longer interval group (n = 1,058), respectively, while the 3-year RFS rates were 80.8% and 71.7%, respectively. In multivariate Cox analysis, the longer interval was associated with an increased risk of mortality (hazard ratio [HR], 1.43; 95% confidence interval [CI], 1.01–2.02; p = 0.046) and recurrence (HR, 1.50; 95% CI, 1.12–1.99; p = 0.006).There was an interaction between the molecular subtype and the surgery interval for OS (pinteraction = 0.014) and RFS (pinteraction = 0.027). After PSM, no significant difference in OS (p = 0.180) and RFS (p = 0.069) was observed between the two groups.
Conclusion
Among LABC patients with a poor response, those with a longer interval between NAC and surgery had worse OS and RFS. The results indicate that these patients should receive modified radical surgery timely, which may in turn improve their prognosis.
6.Evaluation of Screening Model for Advanced Colorectal Adenoma and Traditional Chinese Medicine Tongue Image Analysis Based on Real World Data
Peidi HUANG ; Zishao ZHONG ; Shujun LIU ; Zhenhao YE ; Zhuolin LI ; Sufen WEI ; Haiyan ZHANG ; Beiping ZHANG
Journal of Traditional Chinese Medicine 2023;64(21):2197-2207
ObjectiveTo evaluate the effectiveness and consistency of three commonly used early colorectal cancer screening models for advanced colorectal adenoma as a noninvasive means, and to assess the predictive value of traditional Chinese medicine (TCM) tongue images in the models. MethodsPatients diagnosed with colorectal adenoma who underwent colonoscopy and pathological examination were selected as the study participants. Basic clinical data and tongue image were collected. The prediction models of Asia-Pacific colorectal screening (APCS) model, its revision (M-APCS) and colorectal neoplasia predict (CNP) model were applied to compare the predictive effects of the three models on advanced stage adenomas of the colon, the differences in clinical data and traditional Chinese medicine tongue characteristics among patients with different degrees of adenomas, and the similarities and differences in tongue characteristics among the models. The discriminative ability of the three risk models was evaluated using the area under the curve (AUC) and receiver operating characteristic (ROC) curves. The calibration was assessed using the Kuder-Richardson coefficient and the Hosmer-Lemeshow test for consistency analysis. ResultsA total of 227 patients with adenoma were analyzed, including 104 patients (45.82%) with advanced adenoma. In the detection of advanced adenoma, those with greasy coating (70 cases, 67.3%) were higher than those without greasy coating (34 cases, 32.7%, P<0.05). After multivariate analysis, the odds ratio (OR) value of non-greasy coating was 0.371 (0.204~0.673, P<0.01), indicating that non-greasy coating was a protective factor for advanced adenomas. Among the three risk models, the detection rate of advanced adenoma in the high-risk group with APCS was the highest (63.3%), which was 1.49 times and 2.04 times that of the medium-risk group (42.6%) and the low-risk group (31.1%, P<0.01). The detection rate of advanced adenomas in high-risk groups of M-APCS and CNP was slightly higher than that in moderate or low risk groups (P>0.05). The proportion of yellow and greasy coating in high-risk group was higher than that in the medium-risk or low-risk group (P<0.05). For the ability to distinguish advanced and non-advanced adenomas, the AUC of APCS was 0.629 (95% CI: 0.556~0.702) and was higher than that of M-APCS (0.591) and CNP (0.586). In calibration evaluation, Cronbach's alpha was 0.919 (>0.7), which indicated that the three models were consistent. In the correlation matrix, the correlation coefficients between APCS model and M-APCS model, and CNP model were 0.794 and 0.717, respectively, and the correlation coefficients between M-APCS model and CNP model were 0.873, Hosmer-Lemeshow χ2 =2.552, P>0.05, which suggested that the three models had good calibration ability. ConclusionAll three models demonstrate the efficiency to identify advanced colorectal adenoma, and their calibration ability is considered to be good. Among the three models, the APCS exhibits the highest recognition efficiency, however, the recognition accuracy of the APCS model needs improvement. The presence of a greasy coating is identified as one of the potential predictors of advanced adenoma. Consequently, it can be considered for inclusion in the risk model of advanced colorectal adenoma to enhance the accuracy.
7.Network pharmacology and experimental validation of Maxing Shigan decoction in the treatment of influenza virus-induced ferroptosis.
Jiawang HUANG ; Xinyue MA ; Zexuan LIAO ; Zhuolin LIU ; Kangyu WANG ; Zhiying FENG ; Yi NING ; Fangguo LU ; Ling LI
Chinese Journal of Natural Medicines (English Ed.) 2023;21(10):775-788
Influenza is an acute viral respiratory infection that has caused high morbidity and mortality worldwide. Influenza A virus (IAV) has been found to activate multiple programmed cell death pathways, including ferroptosis. Ferroptosis is a novel form of programmed cell death in which the accumulation of intracellular iron promotes lipid peroxidation, leading to cell death. However, little is known about how influenza viruses induce ferroptosis in the host cells. In this study, based on network pharmacology, we predicted the mechanism of action of Maxing Shigan decoction (MXSGD) in IAV-induced ferroptosis, and found that this process was related to biological processes, cellular components, molecular function and multiple signaling pathways, where the hypoxia inducible factor-1(HIF-1) signaling pathway plays a significant role. Subsequently, we constructed the mouse lung epithelial (MLE-12) cell model by IAV-infected in vitro cell experiments, and revealed that IAV infection induced cellular ferroptosis that was characterized by mitochondrial damage, increased reactive oxygen species (ROS) release, increased total iron and iron ion contents, decreased expression of ferroptosis marker gene recombinant glutathione peroxidase 4 (GPX4), increased expression of acyl-CoA synthetase long chain family member 4 (ACSL4), and enhanced activation of hypoxia inducible factor-1α (HIF-1α), induced nitric oxide synthase (iNOS) and vascular endothelial growth factor (VEGF) in the HIF-1 signaling pathway. Treatment with MXSGD effectively reduced intracellular viral load, while reducing ROS, total iron and ferrous ion contents, repairing mitochondrial results and inhibiting the expression of cellular ferroptosis and the HIF-1 signaling pathway. Finally, based on animal experiments, it was found that MXSGD effectively alleviated pulmonary congestion, edema and inflammation in IAV-infected mice, and inhibited the expression of ferroptosis-related protein and the HIF-1 signaling pathway in lung tissues.
Animals
;
Mice
;
Ferroptosis
;
Network Pharmacology
;
Reactive Oxygen Species
;
Vascular Endothelial Growth Factor A
;
Influenza A virus
;
Iron
;
Hypoxia
8.Analysis of Chemical Drugs Suitable for Children in Chinese Over-the-counter Drugs Catalogue
LU Zhuolin ; WANG Xiaoling ; WANG Yan ; LI Mengxue ; DONG Yawen ; LI Yingchun ; SUN Yanyan
Chinese Journal of Modern Applied Pharmacy 2023;40(17):2456-2461
OBJECTIVE To sort out the chemical drugs for children in China's over-the-counter(OTC) drugs catalogue and analyze the drug categories and the specification of the instructions, so as to find out the key points that lead to the risk of drug use, and put forward suggestions for improvement. METHODS According to the sample of OTC drugs instructions published on the website of the National Medical Products Administration, as well as the results of clinical expert investigation and literature, the OTC drugs catalog of children's chemical drugs was determined and classified, and the investigate the standardization and consistency of the instructions. RESULTS There were 267 kinds of OTC drugs for children sorted out, involving 18 kinds of diseases. A considerable proportion of the instructions were incomplete and nonstandard, and there were few kinds of drugs for respiratory and digestive diseases. CONCLUSION The preparation and publicity of children OTC drugs instructions should be standard, the research and development of children's OTC drugs should be strengthened, the training of pharmacy employees should be strengthened, and ensure the rational and safe use of children's OTC drugs.
9.Investigation and Analysis of the Understanding of Pharmacy Practitioners in Retail Pharmacies and Parents to Children’s OTC Drug Knowledge
Yingchun LI ; Zhuolin LU ; Yan GAO ; Yanyan SUN
China Pharmacy 2021;32(23):2917-2923
OBJECTIVE:To standardize the use of children’s over-the-counter(OTC)drugs in China,control the risk of children’s self medication and ensure the safety of children’s medication. METHODS:The questionnaire was randomly distributed to pharmacy practitioners in retail pharmacies in 13/parents in 16 provinces and municipalities directly under the central government. The results of questionnaire survey were analyzed descriptively. The corresponding suggestions were put forward for the problems existing in the use of OTC drugs for children among pharmacy practitioners in retail pharmacies and parents.RESULTS:Totally 5 367 people filled the questionnaire at pharmacies,and 5 353 questionnaires were filled validly with effective rate of 99.74%;the number of consumers(parents)who filled the questionnaires was 6 111,and 5 094 questionnaires were filled validly with effective rate of 83.36%. The results of survey showed that 93.67% of retail pharmacies were equipped with 1-2licensed pharmacists;most of the employees in pharmacies had college degree(46.59%),and their professional knowledge was relatively weak,and only 30.00% of them were very familiar with pharmaceutical professional knowledge. Pharmacy practitioners could provide basic pharmaceutical care,but they were not sensitive to the information of children’s age and weight;only 44.11%of the practitioners would approve the dosage according to the age and weight of the children;98.09% of pharmacies would regularly conduct OTC drugs knowledge training,but they did not pay attention to the knowledge of children related to drug use. About half of the pharmacy practitioners were very clear about the indications,usage and dosage,precautions of OTC drugs forchildren. About 70% of parents did not fully understand the difference between prescription drugs,green OTC drugs and red OTC drugs,and did not know the risk of home OTC treatment;63.06% of parents chose OTC drugs according to their previous experience, and 23.05% of parents relied on drug advertisements to choose OTC drugs; 92.64% of parents would read the drug instruction carefully before using OTC drugs, but they had blind spots in understanding many contents of the drug instruction. In the process of OTC drug use,46.21% of parents had used adult OTC drugs for their children,and 41.54% of parents did not convert the amount of children;52.89% of parents said that their children suffered from adverse reactions after taking OTC drugs. CONCLUSIONS:The pharmacy practitioners have low education on the whole,professional level needs to be improved,their understanding of children’s OTC drugs is not comprehensive enough,and there is a lack oftraining on children’s medication knowledge. Parents have a poor awareness of children’s OTC drugs,and there are many problems in the process of using children’s OTC drugs,such as inaccurate dosage,using adult’s drugs. It is suggested that we should improve the access standard of pharmacy practitioners and increase the number of licensed pharmacists;organize special training on safe drug use for children to improve the pharmaceutical service ability of pharmacies;strengthen the supervision of retail pharmacies and formulate pharmaceutical care standards for the use of OTC drugs for children;strengthen the publicity and education on rational drug use for children and popularize the knowledge of safe drug use of OTC drugs for children;give full play to the guiding role of pharmacists and pay attention to the medication guidance of parents.
10.The value of synthetic MRI combined with diffusion weighted imaging in differential diagnosis of benign and malignant breast lesions
Shiyun SUN ; Zhuolin LI ; Lisha NIE ; Yifan LIU ; Dongxue ZHANG ; Ke XUE ; Yingying DING
Chinese Journal of Radiology 2021;55(6):597-604
Objective:To evaluate the value of synthetic MRI combined with DWI in the diagnosis of benign and malignant breast lesions.Methods:The data of 184 consecutive patients with suspected breast lesions in Yunnan Cancer Hospital from July to September 2019 were prospectively analyzed. All patients were randomly assigned to training group ( n=110) and validation group ( n=74), and underwent conventional MRI and synthetic MRI respectively before and after contrast injection. At the maximum slice of the lesion, the ROI was drawn along the edge and recorded as "tumor". In the solid area with the most obvious tumor enhancement, the second ROI was drawn and recorded as "local". At the same time, ADC values (ADC local and ADC tumor) and relaxation time values (T local and T tumor) were measured. T and T + represented the relaxation time value of the ROI pre-and post-contrast scanning. ΔT% represented the relative change rate in T value between pre-and post-contrast scanning.The rank sum test was used to test the quantitative parameters of benign and malignant breast lesions in the training group and the validation group, and the variables with P<0.05 were included in the binary logistic regression analysis to screen the independent variables and establish the prediction model. The area under ROC curve was used to evaluate the discrimination of parameters and models. The clinical applicability of model was analyzed by decision curve analysis (DCA). Results:In the training group, univariate analysis showed that there were significant differences in T 1tumor, T 1+tumor, ΔT 1% tumor, T 2local, T 2+local, T 2tumor and T 2+tumor, ADC local, ADC tumor between benign and malignant breast lesions ( P<0.05). Multivariate logistic regression analysis showed that T 1+tumor, ΔT 1% tumor, T 2tumor, ADC local, ADC tumor were independent variables in the diagnosis of breast cancer. The relaxation time model (model A: T 1+tumor, ΔT 1% tumor, T 2tumor) and ADC model (model B: ADC local, ADC tumor) established by combining the above variables had the same diagnostic efficiency (AUC=0.905, 0.914, Z=-1.874, P=0.062), and the multi-parameter combination model (model C: T 1+tumor, ΔT 1% tumor, T 2tumor, ADC local, ADC tumor) had the highest diagnostic efficiency (AUC=0.965). DCA analysis showed that when the threshold probability ranges between 21%-99% (training cohort) and 15%-99% (validation cohort), the net benefit of model C was better than model A and B. Conclusion:The multi-parameter combined prediction model established based on the relaxation time value and ADC can identify breast cancer efficiently and can be used as an auxiliary diagnostic tool.


Result Analysis
Print
Save
E-mail